Detalhe da pesquisa
1.
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients.
J Transl Med
; 15(1): 104, 2017 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28499389
2.
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma.
Sci Rep
; 11(1): 21427, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34728659
3.
CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery.
Sci Rep
; 9(1): 14385, 2019 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591443
4.
The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma.
Haematologica
; 92(8): 1067-74, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17640855
5.
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA).
PLoS One
; 12(9): e0185169, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934318
6.
Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by recombinant adenovirus in patients with metastatic gastrointestinal carcinomas.
J Clin Oncol
; 23(5): 999-1010, 2005 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15598979
7.
Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation.
Leuk Lymphoma
; 47(1): 29-37, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16321824
8.
Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy.
Biomaterials
; 91: 73-80, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26999456
9.
Identification of TIM3 2'-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy.
Oncotarget
; 7(4): 4522-30, 2016 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683225
10.
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells.
Oncotarget
; 7(17): 23182-96, 2016 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26992239
11.
Risk of second cancer in patients with hairy cell leukemia: long-term follow-up.
J Clin Oncol
; 20(3): 638-46, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11821443
12.
Potentiation of therapeutic immune responses against malignancies with monoclonal antibodies.
Clin Cancer Res
; 9(15): 5454-64, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14654524
13.
Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming.
Exp Hematol
; 30(12): 1355-64, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12482496
14.
2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia.
Biomaterials
; 67: 274-85, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26231918
15.
Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma.
Biomed Res Int
; 2015: 648143, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26425548
16.
Variations in "rescuability" of immunoglobulin molecules from different forms of human lymphoma: implications for anti-idiotype vaccine development.
Crit Rev Oncol Hematol
; 52(1): 1-7, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15363462
17.
Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies.
Haematologica
; 89(5): 541-6, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15136216
18.
The role of idiotype vaccines in the treatment of human B-cell malignancies.
Expert Rev Vaccines
; 3(2): 163-70, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15056042
19.
Splenic marginal zone lymphoma with Evans' syndrome, autoimmunity, and peripheral gamma/delta T cells.
Ann Hematol
; 88(2): 177-8, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18665362
20.
Secondary myelodysplastic syndrome after treatment for promyelocytic leukemia: clinical and genetic features of two cases.
Cancer Genet Cytogenet
; 143(2): 178-81, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12781455